Sign in to view content

Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study

Yoshihiro Yonekawa, MD, FASRS

Video
Published 2018

Related

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6
Michael S. Ip, MD
Annual Meeting Talks
2018
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Annual Meeting Talks
2018
Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Inflammatory and Infectious Diseases

See more